logo
Select company
Select metric
$ -3.54EBITDA per Share
VS
Market
7
Sector
18
Industry
23
History
82
$ 12.96Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -256.75M$ -3.54172.47M
3/31/2025$ -272.12M$ -3.78171.97M
12/31/2024$ -261.52M$ -4.14163.18M
9/30/2024$ -272.21M$ -4.21164.63M
6/30/2024$ -238.33M$ -4.07158.56M
3/31/2024$ -196.07M$ -3.36158.37M
12/31/2023$ -159.05M$ -3.1151.29M
9/30/2023$ -137.97M$ -2.43156.78M
6/30/2023$ -146.59M$ -3.02148.5M
3/31/2023$ -160.47M$ -3.79142.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -5.06.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average EBITDAPS has been $ -3.81.
  • The median EBITDAPS for PHATHOM PHARMACEUTICALS INC during this period was $ -3.8
  • PHATHOM PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -2.43.
  • The lowest EBITDAPS recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe $ -5.06

PHATHOM PHARMACEUTICALS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
GYRE : GYRE THERAPEUTICS INC $ 0.11ANAB : ANAPTYSBIO INC $ -4.52NAGE : NIAGEN BIOSCIENCE INC $ 0.25CRMD : CORMEDIX INC $ 0.77TBPH : THERAVANCE BIOPHARMA INC $ 0.96ZYME : ZYMEWORKS INC $ -0.72URGN : UROGEN PHARMA LTD $ -2.81ZVRA : ZEVRA THERAPEUTICS INC $ 0.67XNCR : XENCOR INC $ -1.66KURA : KURA ONCOLOGY INC $ -2.2

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for PHATHOM PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -168.81M ] / (Shares WA [ 33.37M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -5.06 ]

PHAT - EBITDA per Share, Last 5 years

$ -5.06

Minimum

Sep 30, 2020

$ -2.43

Maximum

Sep 30, 2023

$ -3.81

Average

$ -3.8

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26